Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Ju

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Indian Journal of Dermatology, Venereology and Leprology|March 31, 2023
Immunohistochemistry of COVID-19 skinTeresa Ju
Clinical, Cosmetic and Investigational Dermatology|June 15, 2022
Managing Atopic Dermatitis with Lebrikizumab - The Evidence to DateAngelina Labib, Teresa Ju, Gil Yosipovitch
Journal of the American Academy of Dermatology|May 8, 2023
Emerging treatments for itch in atopic dermatitis: A reviewAngelina Labib, Teresa Ju, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|January 27, 2023
When Foods Cause Itch: Clinical Characteristics, Pathophysiology, and Recommendations for Food-Induced Skin and Mucosal PruritusAshley Vander Does, Teresa Ju, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|July 15, 2022
When Foods Cause Itch: Clinical Characteristics, Pathophysiology, and Recommendations for Food-Induced Skin and Mucosal PruritusAshley Vander Does, Teresa Ju, Gil Yosipovitch
NEJM Evidence|December 24, 2024
A 50-Year-Old Man with Left-Sided Weakness and Difficulty Speaking ClearlyIsabella Ferando, Teresa Ju, Vera Sharashidze, et al.
Skin Appendage Disorders|February 5, 2024
Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative ReviewSophia Reyes-Hadsall, Teresa Ju, Jonette E Keri
Immunotargets and Therapy|May 3, 2022
Immunotargets and Therapy for Prurigo NodularisAngelina Labib, Teresa Ju, Ashley Vander Does, et al.
Journal of the American Academy of Dermatology|March 12, 2022
Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case seriesTeresa Ju, Angelina Labib, Ashley Vander Does, et al.
Acta Dermato-Venereologica|October 17, 2022
Lichen Simplex Chronicus Itch: An UpdateTeresa Ju, Ashley Vander Does, Noreen Mohsin, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Indian Journal of Dermatology, Venereology and Leprology|March 31, 2023
Immunohistochemistry of COVID-19 skinTeresa Ju
Clinical, Cosmetic and Investigational Dermatology|June 15, 2022
Managing Atopic Dermatitis with Lebrikizumab - The Evidence to DateAngelina Labib, Teresa Ju, Gil Yosipovitch
Journal of the American Academy of Dermatology|May 8, 2023
Emerging treatments for itch in atopic dermatitis: A reviewAngelina Labib, Teresa Ju, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|January 27, 2023
When Foods Cause Itch: Clinical Characteristics, Pathophysiology, and Recommendations for Food-Induced Skin and Mucosal PruritusAshley Vander Does, Teresa Ju, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|July 15, 2022
When Foods Cause Itch: Clinical Characteristics, Pathophysiology, and Recommendations for Food-Induced Skin and Mucosal PruritusAshley Vander Does, Teresa Ju, Gil Yosipovitch
NEJM Evidence|December 24, 2024
A 50-Year-Old Man with Left-Sided Weakness and Difficulty Speaking ClearlyIsabella Ferando, Teresa Ju, Vera Sharashidze, et al.
Skin Appendage Disorders|February 5, 2024
Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative ReviewSophia Reyes-Hadsall, Teresa Ju, Jonette E Keri
Immunotargets and Therapy|May 3, 2022
Immunotargets and Therapy for Prurigo NodularisAngelina Labib, Teresa Ju, Ashley Vander Does, et al.
Journal of the American Academy of Dermatology|March 12, 2022
Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case seriesTeresa Ju, Angelina Labib, Ashley Vander Does, et al.
Acta Dermato-Venereologica|October 17, 2022
Lichen Simplex Chronicus Itch: An UpdateTeresa Ju, Ashley Vander Does, Noreen Mohsin, et al.
Pageof 2